Delivery Order SPE2DB24D1205-SPE2DB25FCVAG
- Not listed
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,446.06, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a period of performance through April 4, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,955.29, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. It is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of February 14, 2025. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a ceiling value of $4,158.77 and a completion date of February 7, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 500S, a pharmaceutical product, with a ceiling value of $1,559.49. The contract has a firm fixed price pricing type and an ultimate completion date of June 13, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,673.08, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of December 13, 2023. The award is not designated with a set-aside. Amerisourcebergen holds a significant...
- This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,978.44, is for the provision of 4562869415 - TAMSULOSIN HCL 0.4 MG CAPSULE 100S, a generic medication used to treat an enlarged prostate. The contract has a firm fixed price pricing type and a completion date of November 21, 2023. This award is not associated with a...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price of $2,033.85 and a completion date of January 10, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,775.99, is a Delivery Order with a Firm Fixed Price pricing type, awarded by the Defense Logistics Agency (DLA). The contract is for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a medication used in the treatment of various medical conditions. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,927.98, is for the delivery of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat benign prostatic hyperplasia. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 15, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,010.10, is for the supply of 4567645234 TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025 and is a firm fixed-price delivery order contract. This contract award is not designated as a set-aside. AmerisourceBergen...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCVAGDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,623.49, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a medication used to treat benign prostatic hyperplasia. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 19, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 3/18/25 |